Private placement in SpinChip Diagnostics AS (NO) – NOK 130 million

Carnegie acted as manager and sole bookrunner in the private placement of NOK 130 million in new equity by SpinChip Diagnostics. SpinChip Diagnostics is a medical device company who is developing a game changing and proprietary platform for in vitro diagnostics point of care analyses.
June 2021.